MiR-15b-5p inhibits castration-resistant growth of prostate cancer cells by targeting the muscarinic cholinergic receptor CHRM3

FEBS Lett. 2023 Apr;597(8):1164-1175. doi: 10.1002/1873-3468.14598. Epub 2023 Feb 20.

Abstract

Cholinergic receptor muscarinic 3 (CHRM3)-mediated focal adhesion kinase/YES-associated protein (YAP) signalling is essential for the growth of castration-resistant prostate cancer (CRPC) cells. Here, we evaluated the molecular mechanisms through which CHRM3 overexpression facilitates castration-resistant growth. Small RNA sequencing combined with in silico analyses revealed that CHRM3 was a putative target of miR-15b-5p. Notably, androgen deprivation suppressed miR-15b-5p expression and increased CHRM3 expression. Moreover, miR-15b-5p bound directly to CHRM3 and inhibited YAP activation induced by CHRM3 stimulation. Furthermore, miR-15b-5p abolished the growth of CRPC cells induced by CHRM3 stimulation. We conclude that the miR-15b-5p/CHRM3/YAP signalling axis promotes the castration-resistant growth of prostate cancer.

Keywords: Hippo-YAP signalling; castration resistance; miR-15b-5p; muscarinic receptor 3; prostate cancer.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Androgen Antagonists
  • Castration
  • Cell Line, Tumor
  • Cell Proliferation / physiology
  • Cholinergic Agents
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Male
  • MicroRNAs* / genetics
  • Prostatic Neoplasms, Castration-Resistant* / genetics
  • Prostatic Neoplasms, Castration-Resistant* / metabolism
  • Receptor, Muscarinic M3 / genetics
  • Receptor, Muscarinic M3 / metabolism
  • Receptors, Cholinergic / metabolism

Substances

  • MicroRNAs
  • Androgen Antagonists
  • Receptors, Cholinergic
  • Cholinergic Agents
  • CHRM3 protein, human
  • Receptor, Muscarinic M3